Tuesday, November 12, 2013

Sharebuilder DRIP Purchases- KMI, TEVA, CAT KMR

Reporting my weekly buys that went through last week and today.

Last weeks purchases 11/5 (Dow 15,618):
  • $200 of KMI at $35.19. Yield 4.66%.
  • $200 of TEVA at $36.55. Yield 2.81%.
  • $200 of CAT at $83.48. Yield 2.88%. 
$600 of new capital invested adding $20.54 to my annual dividend income.

This weeks purchases (Dow 15,751):
  • $250 of KMI at $34.66. Yield 4.73%.
  • $250 of KMR at $74.45. Yield 7.25%. 
  • $250 of TEVA at $37.53. Yield 2.66%.
 $750 of new capital invested adding $36.62 to my annual dividend income.

Note: TEVA share price has taken a hit over the unexpected resignation of the CEO.  I made my initial purchases about 2 1/2 years ago and its one of the few positions I have that is in the red.  This one takes patience.


  1. Hi AA,
    I've been in and out of Teva over the last few years. That one continues to disappoint me. It has so much promise, but I just can't figure out where it's going wrong. It is fundamentally a commodity business, which competes primarily on price, but generics are a growing field and Teva has an extensive distribution network.

    Good job with the DRIPs. I have several I've held for years and they have done really well over time.

  2. Fast Weekly,

    Thanks for stopping by.

    I agree with you on TEVA. Its cheap, is shareholder friendly, and is the largest generic in the world with an aging western population to benefit from its products. Yet it just sits there. I do think patient shareholders will eventually be rewarded. And this one takes some serious patience.